Drug-majors Ranbaxy and Pfizer have formalised an alliance with fast-moving-consumer-goods (FMCG) company ITC to tap the rural markets for their over-the-counter (OTC) products. The three companies are reported to have undertaken a pilot project in Uttar Pradesh. Ranbaxy's OTC products include energy-supplement Revital, antacid Pepfiz, pain balm and spray Volini and cough syrup Chericof Ranbaxy's global OTC business stood at Rs 248 crore last year, a growth of 17 per cent.
Pfizer India's consumer health portfolio includes brands such as Gelusil, Nebasulf, Selsun, Ferradol, and Waterbury's Compound. However, it has globally sold its OTC brands – mouth-wash Listerine, cough-syrup Benadryl, skin-cream Caladryl and cough-suppressant Benylin to Johnson & Johnson.
The distribution reach of an FMCG company into rural areas in India is much wider than that of a pharmaceutical company, he observed. The domestic OTC products market is pegged at over Rs 4,000 crore, growing at 12-14 per cent.
| Company Name | CMP |
|---|---|
| ITC | 298.65 |
| Godfrey Phillips | 2042.00 |
| VST Industries | 226.20 |
| The Indian Wood Pro. | 31.63 |
| NTC Industries | 155.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: